These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25534422)

  • 1. Evaluation of pharmacist care for hypertension in the Veterans Affairs patient-centered medical home: a retrospective case-control study.
    Zillich AJ; Jaynes HA; Bex SD; Boldt AS; Walston CM; Ramsey DC; Sutherland JM; Bravata DM
    Am J Med; 2015 May; 128(5):539.e1-6. PubMed ID: 25534422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multimodal blood pressure control intervention in 3 healthcare systems.
    Magid DJ; Ho PM; Olson KL; Brand DW; Welch LK; Snow KE; Lambert-Kerzner AC; Plomondon ME; Havranek EP
    Am J Manag Care; 2011 Apr; 17(4):e96-103. PubMed ID: 21774100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a pharmacy care management program for veterans with dyslipidemia.
    Smith MC; Boldt AS; Walston CM; Zillich AJ
    Pharmacotherapy; 2013 Jul; 33(7):736-43. PubMed ID: 23625745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study.
    Fikri-Benbrahim N; Faus MJ; Martínez-Martínez F; Sabater-Hernández D
    Res Social Adm Pharm; 2013; 9(6):797-805. PubMed ID: 23391845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
    McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT;
    Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION).
    Tsuyuki RT; Houle SK; Charrois TL; Kolber MR; Rosenthal MM; Lewanczuk R; Campbell NR; Cooney D; McAlister FA;
    Circulation; 2015 Jul; 132(2):93-100. PubMed ID: 26063762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.
    Robinson JD; Segal R; Lopez LM; Doty RE
    Ann Pharmacother; 2010 Jan; 44(1):88-96. PubMed ID: 20040704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes.
    Sookaneknun P; Richards RM; Sanguansermsri J; Teerasut C
    Ann Pharmacother; 2004 Dec; 38(12):2023-8. PubMed ID: 15522983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between hypertension-specific care management processes and blood pressure outcomes in US-based physician organizations.
    Wong K; Smalarz A; Wu N; Boulanger L; Wogen J
    J Am Soc Hypertens; 2011; 5(6):505-12. PubMed ID: 21958468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist intervention program for control of hypertension.
    Chabot I; Moisan J; Grégoire JP; Milot A
    Ann Pharmacother; 2003 Sep; 37(9):1186-93. PubMed ID: 12921497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight.
    John EJ; Vavra T; Farris K; Currie J; Doucette W; Button-Neumann B; Osterhaus M; Kumbera P; Halterman T; Bullock T
    Pharmacotherapy; 2006 Oct; 26(10):1511-7. PubMed ID: 16999661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program.
    Magid DJ; Olson KL; Billups SJ; Wagner NM; Lyons EE; Kroner BA
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):157-63. PubMed ID: 23463811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting.
    Carter BL; Barnette DJ; Chrischilles E; Mazzotti GJ; Asali ZJ
    Pharmacotherapy; 1997; 17(6):1274-85. PubMed ID: 9399611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery disease and hypertension: outcomes of a pharmacist-managed blood pressure program.
    McConnell KJ; Zadvorny EB; Hardy AM; Delate T; Rasmussen JR; Merenich JA;
    Pharmacotherapy; 2006 Sep; 26(9):1333-41. PubMed ID: 16945056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study).
    Zillich AJ; Sutherland JM; Kumbera PA; Carter BL
    J Gen Intern Med; 2005 Dec; 20(12):1091-6. PubMed ID: 16423096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial.
    Cooney D; Moon H; Liu Y; Miller RT; Perzynski A; Watts B; Drawz PE
    BMC Nephrol; 2015 Apr; 16():56. PubMed ID: 25881226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults.
    Taveira TH; Dooley AG; Cohen LB; Khatana SA; Wu WC
    Ann Pharmacother; 2011 Nov; 45(11):1346-55. PubMed ID: 22028418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):103-8. PubMed ID: 21293325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.